Steris (FRA:2TG) Beneish M-Score: -2.67 (As of Jun. 25, 2026)


FRA:2TG Steris PLC FRA:2TG
90 GF Score
Price €183.80
GF Value €238.39
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Steris Beneish M-Score?

Steris FRA:2TG +11.53% 90 Beneish M-Score is -2.67 as of Jun. 25, 2026. GuruFocus rates FRA:2TG with a GF Score™ of 90/100 and a GF Value™ of €238.39 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 766 Medical Devices & Instruments companies, Steris ranks better than 57.57% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.67 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Steris's Beneish M-Score or its related term are showing as below:

FRA:2TG' s Beneish M-Score Range Over the Past 10 Years
Min: -2.72   Med: -2.64   Max: -2.43
Current: -2.67

During the past 13 years, the highest Beneish M-Score of Steris was -2.43. The lowest was -2.72. And the median was -2.64.


Steris Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Steris's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steris Beneish M-Score Chart

Steris Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.43 -2.67 -2.63 -2.55 -2.67

Steris Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.55 -2.63 -2.69 -2.61 -2.67

FRA:2TG vs ZBH, GEHC, DXCM: Beneish M-Score Comparison

For the Medical Devices subindustry, Steris's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steris Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Steris's Beneish M-Score falls into.


FRA:2TG
90GF Score
Steris PLC FRA:2TG
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steris Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Steris for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9716+0.528 * 0.9948+0.404 * 0.9439+0.892 * 1.0074+0.115 * 1.0682
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9703+4.679 * -0.051164-0.327 * 0.9487
=-2.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was €945 Mil.
Revenue was 1373.966 + 1277.755 + 1244.176 + 1206.084 = €5,102 Mil.
Gross Profit was 602.991 + 559.797 + 550.307 + 544.476 = €2,258 Mil.
Total Current Assets was €2,071 Mil.
Total Assets was €9,288 Mil.
Property, Plant and Equipment(Net PPE) was €2,004 Mil.
Depreciation, Depletion and Amortization(DDA) was €418 Mil.
Selling, General, & Admin. Expense(SGA) was €1,210 Mil.
Total Current Liabilities was €990 Mil.
Long-Term Debt & Capital Lease Obligation was €1,672 Mil.
Net Income was 190.473 + 164.651 + 163.499 + 153.806 = €672 Mil.
Non Operating Income was 0.259 + -3.16 + -2.045 + -1.561 = €-7 Mil.
Cash Flow from Operations was 290.121 + 254.663 + 245.206 + 364.14 = €1,154 Mil.
Total Receivables was €966 Mil.
Revenue was 1369.555 + 1308.828 + 1197.339 + 1188.656 = €5,064 Mil.
Gross Profit was 593.11 + 582.837 + 521.499 + 531.76 = €2,229 Mil.
Total Current Assets was €1,851 Mil.
Total Assets was €9,386 Mil.
Property, Plant and Equipment(Net PPE) was €1,954 Mil.
Depreciation, Depletion and Amortization(DDA) was €442 Mil.
Selling, General, & Admin. Expense(SGA) was €1,238 Mil.
Total Current Liabilities was €946 Mil.
Long-Term Debt & Capital Lease Obligation was €1,890 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(945.272 / 5101.981) / (965.7 / 5064.378)
=0.185275 / 0.190685
=0.9716

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2229.206 / 5064.378) / (2257.571 / 5101.981)
=0.440174 / 0.442489
=0.9948

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2071.329 + 2003.772) / 9287.678) / (1 - (1850.74 + 1954.432) / 9385.79)
=0.561236 / 0.594582
=0.9439

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5101.981 / 5064.378
=1.0074

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(441.945 / (441.945 + 1954.432)) / (418.137 / (418.137 + 2003.772))
=0.184422 / 0.172648
=1.0682

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1209.86 / 5101.981) / (1237.731 / 5064.378)
=0.237135 / 0.244399
=0.9703

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1671.612 + 990.425) / 9287.678) / ((1890.052 + 945.535) / 9385.79)
=0.28662 / 0.302115
=0.9487

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(672.429 - -6.507 - 1154.13) / 9287.678
=-0.051164

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Steris has a M-score of -2.73 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.67 mean?
Steris (FRA:2TG) has a Beneish M-Score of -2.67 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Steris and its competitors. According to the industry distribution chart, Steris ranks #325 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 42.4%.
Is Steris' Beneish M-Score too high?
Steris' current Beneish M-Score is -2.67. Based on the distribution chart, Steris ranks #325 out of 766 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Steris has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Steris' Beneish M-Score compare to ZBH and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Steris ranks #325 out of 766 companies for Beneish M-Score. This puts Steris in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Steris and its competitors. Steris's current Beneish M-Score is -2.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Based on GuruFocus' analysis, Steris (FRA:2TG) is currently considered Modestly Undervalued. The stock's GF Value™ is €238.39, compared to a current price of €183.80 — trading 22.9% below its estimated fair value. The current Beneish M-Score is -2.67. Steris' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Steris (FRA:2TG), the current Beneish M-Score is -2.67 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Steris (FRA:2TG) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of €183.80 is trading 22.9% below its estimated GF Value™ of €238.39. GuruFocus considers Steris to be Modestly Undervalued.

Key valuation signals for FRA:2TG:

  • Beneish M-Score: -2.67
  • GF Value™: €238.39 vs. price of €183.80 (22.9% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the FRA:2TG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Steris Business Description

Other Exchanges STE:USAS1TE34:Brazil
Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score

Get the complete analysis for FRA:2TG

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€183.80
Price
€238.39
GF Value